Pediatric Exanthems and rashes - PowerPoint PPT Presentation

1 / 81
About This Presentation
Title:

Pediatric Exanthems and rashes

Description:

Pediatric Exanthems and rashes + + + + + * Measles girl: unwell looking Exanthem: Maculopapular; starts on face; cranio-caudal spread is typical; rarely involves ... – PowerPoint PPT presentation

Number of Views:1837
Avg rating:3.0/5.0
Slides: 82
Provided by: nhedventu
Category:

less

Transcript and Presenter's Notes

Title: Pediatric Exanthems and rashes


1
Pediatric Exanthems and rashes
2
Viral
  • Classic
  • I Measles (Rubeola)
  • II Scarlet Fever
  • III Rubella (German measles)
  • IV Filatow-Dukes disease
  • V Erythema Infectiosum
  • VI Roseola Infantum

3
  • Other
  • Herpes
  • HSV 1 and 2
  • Varicella-zoster
  • Cytomegalovirus
  • Epstein-Barr virus
  • Human Herpes virus 6 and 7
  • Human herpes virus 8
  • Enterovirus
  • Coxsackie A16
  • Coxsackie A

4
  • Bacterial
  • Group A Streptococcus
  • Other
  • Gianotti-Crosti
  • Unilateral laterothoracic exanthem
  • Pityriasis Rosea

5
Measles
  • Paramyxovirus
  • Incubation period 7 14 days
  • Infectious period 1- 2 days before prodrome to 4
    days after onset of rash
  • Very infectious (90 attack rates in household
    contacts)
  • Droplet spread oral secretions
  • Typical course 7-10 days (without complications
  • Risk factors non-vaccination

6
Measles clinical features
  • Prodrome day 7-14 after exposure
  • Fever
  • Cough
  • Coryza
  • Conjunctivitis
  • Kopliks spots (1-2 days before rash)
  • Rash (D3-7) started behind ears
  • Miserable

7
Measles Fever Triad
8
Measles exanthem
9
Measles complications
  • Respiratory
  • Common
  • Secondary bacterial inftection
  • OM
  • LTB
  • Cardiac
  • Myocarditis
  • Pericarditis
  • ECG Changes

10
Measles Complications
  • Neurological
  • Abnormal EEG common
  • Encephalitis
  • 11000
  • Usually during exanthem
  • 25 sequalae
  • CSF increased wcc (pleocytosis), protein

11
Measles Complications
  • Others
  • Black measles (haemorrhagic skin eruption)
  • SSPE
  • 0.6/100,000
  • Mean incubation 7 years
  • Increased CSF IgG
  • 6-9 months until death
  • Keratitis (blindness)

12
Measles diagnosis
  • Serology
  • IgM
  • Detectable 3 30 days after exanthem
  • IgG
  • Detectable from 7 days after the exanthem appears

13
Scarlet Fever
  • Group A beta-haemolytic streptococcus
  • Primary
  • Pharyngitis
  • Skin
  • Cellulitis
  • Impetigo
  • Non-Suppurative complications
  • Scarlet fever
  • Streptococcal toxic shock syndrome
  • Acute glomerulonephritis
  • Acute rheumatic fever
  • Suppurative complications
  • Tonsillar abscess
  • OME
  • Necrotizing fasciitis

14
GAS
  • Aerobic gram-positive coccus
  • Forms chains

15
Scarlet Fever
  • Symptoms of primary infection, ie pharyngitis
  • Strawberry tongue
  • Perioral pallor

16
Scarlet fever Rash
17
Scarlet fever rash
18
Scarlet Fever rash
19
Streptococcal Toxic Shock Syndrome
  • Definition GAS infection associated with the
    acute onset of shock and organ failure
  • Virulence factors
  • M protein (Type 1, 3, 12, 28 most commonly
    isolated)
  • Anti-phagocytic, cell membrane protein
  • Exotoxins (SPEA, SPEB)
  • Streptococcal pyrogenic exotoxin A,B
  • Trigger inflammatory cytokine release

20
Streptococcal Toxic Shock Syndrome Clinical
Features
  • Fever
  • Hypotension
  • Altered mental status (50)
  • Multiorgan dysfunction
  • Renal (All)
  • ARDS 55
  • Influenza-like syndrome (20)
  • Soft tissue infection
  • Progresses to fasciitis/myositis 70-80
  • Scarlatinaform rash (10)

21
Staphylococcal toxic shock syndrome vs
Streptococcal
  • Findings Staph Strep
  • Age 15-35 20-50
  • Sex FgtM FM
  • Local invasive
  • Disease Absent Present
  • Generalized
  • Erythroderma Present Absent
  • N/V/D Present Absent
  • Bacteraemia Uncommon 60
  • Mortality 3 30

22
Streptococcal Toxic Shock Syndrome Diagnosis
  • Working Group on Severe Streptococcal Infections
  • Isolation of GAS from a normally sterile site
  • Plus
  • Hypotension
  • Plus gt 2 of the following
  • Renal impairment
  • Coagulopathy
  • Liver impairment
  • ARDS
  • Erythematous macular rash, may desquamate
  • Soft tissue necrosis

23
Rubella
  • Togavirus
  • Incubation period 2 - 3weeks
  • Transmission droplet

24
Rubella Clinical Features
  • Mild/subclinical
  • Prodrome
  • Eye pain, conjunctivitis, headache, fever,
    malaise
  • Rash
  • Maculopapular
  • Starts on face, spreads caudally to trunk,
    extremities
  • Similar to Measles, but spreads quicker
  • Lymphadenopathy
  • Posterior cervical, posterior auricular,
    suboccitpital
  • Forchheimer spots (20)
  • Petechiae on soft palate

25
(No Transcript)
26
Rubella complications
  • Joints
  • Arthralgia/arthritis
  • Rare in children
  • Lasts about 9 days
  • Neurological
  • Encephalitis rare
  • 2-4 days after rash
  • Parasthesia
  • Other
  • Thrombocytopaenia
  • Purpura
  • Myocarditis
  • Testicular pain
  • Haemolytic anaemia

27
Rubella Diagnosis
  • Serology
  • Rubella IgM (false positive EBV, CMV)
  • Follow-up serology 4 weeks (paired sera)
  • Treatment
  • Supportive

28
Erythema Infectiosum
  • Parvovirus B19
  • Common 5-10 aged 2-5 seropositive
  • Incubation
  • 4 14 days
  • Replicates in erythroid progenitor cells in bone
    marrow/blood ? anaemia

29
(No Transcript)
30
Erythema Infectiosum Clinical
  • Biphasic illness
  • Non-specific prodrome (fever, headache, myalgias
    (5-7 days after infection)
  • 1 week later rash (slapped cheek, reticular
    rash extremities)
  • Papular-pruritic glove and sock syndrome
  • Arthritis/arthralgia
  • Aplastic crisis

31
EI rare manifestations
  • Arthritis
  • Association b/w B19 and RA
  • Neurological
  • Encephaliis
  • Meningitis
  • GB syndrome
  • Facial palsy
  • CT syndrome
  • Myocarditis
  • Cutaneous
  • EM
  • HSP
  • Petechiae
  • Haematological
  • TTP
  • Pancytopaenia
  • Haemophagocytic
  • DB anaemia

32
EI Slapped cheek
33
Parvovirus B19 reticular/lace rash
34
Papular-pruritic glove and sock syndrome
35
EI Treatment
  • Paracetamol, Ibuprofen
  • IVIG only in patients with aplasia
  • Supportive

36
HHV 6 Roseola Infantum
  • DNA virus
  • Sixth disease
  • Incubation 9 days
  • Transmission oral secretions
  • 80 children seropositive by age 1
  • Peak infection 9 21 months

37
HHV6 Clinical
  • Fever and convulsion (6-15)
  • Diarrhoea (70)
  • Usually well
  • Rash
  • evolves over 12 hours, fades 2-3 days
  • Appears as fever abates
  • Starts on neck/trunk, spreads to extremities
  • Erythematous, blanching, macular/mac-papular
  • Bulging fontanelle (25)

38
HHV6 Rash
39
HHV6 treatment
  • Supportive
  • Anti-virals in immunocompromised

40
Varicella Zoster
  • DNA virus
  • Incubation 10-21 days
  • Tramission Droplet
  • Highly infectious (1-2 days before rash, until
    crusts)

41
Chickenpox clinical
  • Prodrome
  • Fever
  • Headache
  • Malaise
  • Pharyngitis
  • Rash
  • Pruritic
  • Macules ? papules ? vesciles
  • Hairline

42
Chickenpox Rash
43
VZV Chickenpox Complications
  • Skin
  • Cellulitis (GAS)
  • Neurological
  • Encephalitis
  • Acute cerebellar ataxia (14000)
  • Diffuse encephalitis (1100,000)
  • Reye Syndrome
  • No salicylates
  • N/V, headache, excitability, delirium
  • Respiratory
  • Pneumonia (SA, GAS)
  • Zoster

44
CMV
  • DNA virus (HHV)
  • 60-70 seroprevalence
  • Infection usually asymptomatic
  • Most improtant cause of congenital infection
  • Important in immunocompromised hosts
  • Associated with malignant transformation

45
CMV Clinical
  • Immunocompetent
  • 90 asymptomatic
  • Fever and lethargy up to 4 weeks
  • Usually self-limiting
  • Immunocompromised
  • CMV pneumonitis (90 mortality)
  • GIT disease
  • CMV retinitis

46
CMV Diagnosis, Treatment
  • Diagnosis
  • PCR and CMV antigenaemia
  • Treatment
  • Nucleosides (Target DNA polymerase)
  • Ganciclovir and cidofovir
  • Foscarnet

47
ZIG immunoglobulin
  • Indications
  • Neonates whose mother develops VZV from 5 days
    prior to 2 days after delivery
  • Neonates if mother no history or negative
    serology
  • Premature infants lt 28/40
  • Where vaccine may be contrindicated

48
Enteroviruses
  • Picornaviridae family
  • RNA virus
  • Transmission
  • Faecal-oral
  • Respiratory secretions (CoxsackieA21)
  • Droplets (Enterovirus 70)

49
Enterovirus
  • Poliovirus subclinical, aseptic meningitis,
    paralytic poliomyelitis
  • Non-polio virus
  • Coxsackie A HFMD, Herpangina
  • Coxsackie B Herpangina, pleurodynia,
    myocarditis, pericarditis, meningoencephal
    itis
  • Echovirus URTI, aseptic meningitis, acute
    haemorrhagic conjunctivitis
  • Enterovirus Gastroenteritis

50
Herpangina
  • Coxsackie A16, Enterovirus 71
  • Mainly 3-10yo
  • Fever, sore throat, odonyphagia
  • Vesicular enanthem on the tonsillar fauces, soft
    palate, posterior pharynx
  • Conservative, symptomatic Rx

51
(No Transcript)
52
HMFD
  • Coxsackie A16, enterovirus 71
  • Summer
  • Hihgly infectious
  • Prodrome
  • Vesicular eruptions of hands, feet, oral cavity
  • Conservative, symptomatic Rx

53
(No Transcript)
54
(No Transcript)
55
Pityriasis rosea
  • ?viral aetiology
  • Mulitple viruses implicated
  • Often viral prodrome
  • Herald patch
  • Single scaling patch
  • Appears 1-21 ays prior to general rash

56
Herald patch
57
Herald patch
58
Pityriasis rosea
  • Scaly patches/plaques
  • Chest and back
  • Uncommon on face/scalp
  • Smaller than herald patch
  • Follow Langers lines
  • Collagen bundle direction
  • Christmas tree distribution
  • Pruritic (75)

59
Pityriasis rosea
60
Pityriasis rosea
61
Langers Lines
62
Distribution along Langers lines
63
Pityriasis rosea
  • Symptomatic treatment
  • Lasts 6-12 weeks
  • Some cases photosensitive
  • ?non-infectious

64
Pityriasis lichenoides
  • ?Aetiology
  • Post-infectious
  • T-cell lymphoproliferative disorder
  • Immune-complex mediated hypersensitivity
    vasculitis
  • Pityriasis lichenoides chronica (PLC)
  • Pityriasis lichenoides et varioliformis acuta
    (PLEVA)

65
Pityriasis lichenoides (PLC)
  • Various stages
  • Small pink papule ? reddish-brown
  • A fine mica-like adherent scale attached to a
    central spot
  • Spot flattens out spontaneously leaving behind a
    brown mark, which fades over months
  • Commonly trunk, buttocks, arms, legs
  • Not itchy/irritable

66
Pink papule
67
Scaly plaque
68
PLEVA
  • Red patches that evolve quickly into papules
    5-15mm diameter
  • Often covered in mica-like scale
  • Papules can contain pus/blood
  • Trunk , extremities commonly, but can be
    widespread
  • Pruritic and burning sensation

69
PLEVA
70
Kawasaki Disease
  • Systemic vasculitis
  • Aetiology
  • Still unkown
  • Predominantly lt 5yo
  • Diagnostic criteria
  • Fever for 5 days
  • PLUS 4 of 5
  • Polymorphous rash
  • Bilateral (non purulent) conjunctivitis (90)
  • Mucous membrane changes
  • Erythema, fissuring of lips
  • Strawberry tongue
  • Peripheral changes
  • Erythema of palms/soles
  • Oedema of hands/feet
  • Desquamation in convalescent phase
  • Cervical lymphadenopathy (75)
  • gt15mm
  • Usually unilateral, single, painful

71
Important complication
  • Coronary artery abnormalities
  • Aneurysms
  • An unfavourable outcome
  • Related to duration of fever

72
Atypical Kawasaki disease
  • Usually at extremes of age
  • Additional diagnostic criteria to aid in
    diagnosis
  • ?associated with higher rate of coronary artery
    complications

73
(No Transcript)
74
Rash
  • Polymorphous
  • Macular/papular/morbilloform/scarlatiniform/urtica
    rial/erythrodermatous
  • Never vesicular or bullous
  • Associated with desquamation of perineal region
    days later

75
Polymorhous rash
76
Mucous membrane changes
77
Conjunctivitis
78
Palmar erythema
79
Peripheral oedema
80
Investigations
  • FBE
  • Neutrophilia
  • Thrombocytosis
  • Normochronic, normocytic anaema
  • ASOT
  • CRP
  • ESR
  • LFT
  • Hypoalbuminaemia
  • Elevated liver enzymes
  • Echocardiogram

81
Management
  • IVIG
  • 2g/kg over 10 hours
  • Preferably within first 10 days of illness
  • Aspirin
  • 3-5mg/kg once a day for 6-8weeks
  • For coronary complications
Write a Comment
User Comments (0)
About PowerShow.com